[ad_1]
Korea has long ceased to use hydroxychloroquine, a malaria drug that was recently confirmed to be ineffective for treating Covid-19 infections, according to health officials.
In June, Kwon Jun-wook, deputy director of Korea Disease Control and Prevention, said the nation was not conducting clinical trials to verify the safety and efficacy of hydroxychloroquine on Covid-19 due to its various side effects even earlier. of US Food. and the Drug Administration has stopped emergency use of the drug.
On Wednesday, a Spanish research team presented the results of a randomized clinical trial involving 2,314 people who had contacted confirmed patients. The researchers said they failed to find the significant efficacy of hydroxychloroquine in preventing or treating the novel coronavirus infection.
Among the 2,314 participants, the research team placed 1,116 people in the hydroxychloroquine administration group and the remaining members in a general treatment group. In 14 days, researchers confirmed 138 cases of Covid-19 out of 2,314 people. However, they could not find a significant difference between the two groups as 64 people who were given hydroxychloroquine and 74 participants who received general treatment tested positive.
Side effects occurred more in the hydroxychloroquine administration group than in the general treatment group, but these symptoms were not severe.
“Hydroxychloroquine did not reduce transmission of the Covid-19 virus or the formation of antibodies that fight the disease,” the research team noted. “The results provided evidence that hydroxychloroquine does not help prevent Covid-19 infection or the development of symptoms.”
US President Donald Trump praised hydroxychloroquine, describing it as a “game changer” in the fight against the Covid-19 pandemic. However, the US National Institute of Health recently announced that it could not find the effective drug on Covid-19.
Source link
